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Tuesday, March 3, 2009 487awithin the open-closed cycle. This reveals that the outermost transmembrane
domain is important for appropriate gating and shows a high conservation of
M4 function among members of this superfamily.
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Neurotransmitter-gated receptors play a vital role in the regulation of nocicep-
tion. In the adult CNS, the ionotropic glycine and GABA receptors are typically
inhibitory and act to silence neurons by transiently permitting inward Cl cur-
rents upon activation. However, depending on the Cl equilibrium potential,
these receptors may instead depolarize neurons. We hypothesized that targeted
expression of the a1 subunit of glycine receptor (GlyR) in peripheral sensory
neurons using a non-replicating herpes simplex virus (HSV)-based vector
might reduce nociceptive behavior upon subsequent GlyR activation by exog-
enously-applied glycine. HSV-directed expression of the human a1 subunit of
GlyR alone is sufficient to produce glycine-gated chloride currents in whole-
cell patch clamp studies of infected mammalian cells. In cultured dorsal root
ganglion neurons, expressed GlyRs are diffusely localized in the neuronal
plasma membrane. In both a formalin footpad model of inflammatory pain or
an osteosarcoma pain model, rats inoculated with the GlyR-expressing vector
(vHGlyRa1) exhibited significantly reduced nociceptive behavior following
subcutaneous injection of glycine into the footpad. This reduction in pain-re-
lated behavior was reversed following injection of the GlyR antagonist strych-
nine. Targeted expression of GlyRs and their modulation via mutagenesis and/
or exogenous application of agonists, antagonists, and allosteric modulators of-
fer a novel and potentially powerful method to alter neuronal activity. Here we
show that selective activation of HSV-directed a1 GlyR expression in periph-
eral neurons eliminates pain-related behavior in two pain models, and has the
potential to be used therapeutically for pain management.
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Simultaneously measuring both the ligand-binding and the gating of ligand-
gated ion channels will provide important novel insight in receptor and channel
function (see e.g. Edelstein et. al.). Such measurements require a fluorescently
labeled agonist as ligand, single molecule sensitive optical and electrical detec-
tion, micro-second time-resolution, and optimal alignment of the optical and
electrophysiological single-channel acquisition parts.
Here we present first results from simultaneously measurements of ligand-bind-
ing and channel gating of individual prototypical ligand-gated ion channels in
living cells, using APD-based fast confocal detection and conventional patch-
clamping in single channel mode. In order to reach a reasonable throughput of
experiments, it was essential that the sample, patch-pipette and the confocal vol-
ume could be moved independently and be aligned with micrometer precision.
We show data from nicotinic-acetylcholine receptors, expressed in HEK293
cells and fluorescently labeled epibatidine as agonist, to elucidate details of
the channel gating.
S.J. Edelstein, O. Schaad & J.P. Changeux: Biochmistry;1997; 36(45), 13755
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The GABAA receptor is a member of the cys-loop family of ligand gated ion
channels and the major mediator of neuronal inhibition. Each receptor is a pen-
tameric protein complex composed of homologous subunits, the combination of
which gives rise to numerous GABAA receptor subtypes. Within the thalamus,
two synaptic GABAA receptor isoforms predominate; the a1b2g2 channels,
which are found at the synapses of relay neurons, and the a3b3g2 channels that
are located at synapses in the reticular nucleus. We endeavoured to characterize
the kinetic properties to these two GABAA receptors. Our preliminary data sug-
gest that both receptors open to a single channel conductance level of 26 pS, ir-
respective of the GABA concentration used to elicit activity. a3b3g2 GABAA re-
ceptors, however, exhibit longer active periods (bursts) at saturating (5mM) and
low (2 mM) concentrations of GABA compared to a1b2g2 GABAA receptors.
The mean burst length and intra-burst open probability (Po) for the a3b3g2 chan-
nels was 136.75 16.8 ms and 0.845 0.05 (n ¼ 4), respectively and for thea1b2g2 channels was 87.45 12.0 ms and 0.825 0.02 (n ¼ 3), respectively,
when exposed to 5 mM GABA. At 2 mM GABA, the mean burst length and Po
for a3b3g2 channels was 25.85 4.7 ms and 0.785 0.03 (n ¼ 3), respectively
and fora1b2g2 channelswas 8.45 1.9ms and 0.735 0.02 (n¼ 3), respectively.
These measurements are consistent with the reported slower deactivation phase
of ensemble, a3b3g2 mediated synaptic currents and suggest that GABA has
a longer occupancy at a3b3g2 channels than at a1b2g2 channels.
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The nitroindoline caged amino acids are hydrolytically stable and have photo-
chemical and pharmacological properties suitable for characterising neurotrans-
mitter receptors. Although the NI andMNI - caged glutamates show no interfer-
ence in the activation of glutamate receptors at 10 mM concentration range, the
corresponding GABA and glycine NI derivatives showed evidence of binding
and interference in the amplitude and kinetics of activation at their respective re-
ceptors at 0.1mMconcentrations. Similarly interferencewithGABAergic trans-
mission by 50 mMCNB-caged GABA has also been reported. We describe here
a nitroindoline cagedGABAmodified by addition of a biphosphate on the caging
groupwith the idea that the high negative chargewill impede binding of the cage
to the GABA receptor. Experiments to test the inhibition of miniature GABA
mediated synaptic events in cerebellar molecular layer interneurons showed
much reduced inhibition, approximately 66% inhibition of amplitude at 1 mM
DPNI-GABA. However, with laser pulses of 0.1 ms at 1 mM DPNI-GABA
the 10-90% risetimes were comparable with synaptically evoked currents, indi-
cating that equilibration of the cage with the receptor is fast and interferes little
with kinetic measurements. The decline of laser evoked currents was prolonged
compared with spontaneous events suggesting that the effective volume of
GABA release in the laser spot is larger than synaptic release. The precision
of locating GABA ‘hot spots’ in the focal plane was estimated to decline 50%
in 1.75 microns, permitting detailed mapping of the distribution of receptors
over neuronal compartments. Furthermore, at 100 mM DPNI-GABA, where
there is no interference with receptor activation, photolysis localised to the
soma of Purkinje neurons or interneurones suppressed spiking with millisecond
precision, providing a useful tool for network analysis.
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Neuroactive steroids are efficacious potentiators of GABA-A receptors. Recent
work identified a site in the a1 subunit of the GABA-A receptor which is essen-
tial for potentiation by steroids. However, each receptor contains two copies of
the a1 subunit, leading to questions of whether both sites are required and
whether the sites mediate distinguishable effects. We generated subunit conca-
temers so the a1 subunits could be mutated separately, and examined conse-
quences of a mutation which removes potentiation by most neurosteroids (a1
Q241L) and a mutation which mimics the presence of bound steroid (a1
Q241W). Concatemers were expressed in Xenopus oocytes, and activation by
GABA, potentiation by neuroactive steroids and the agonist activity of the par-
tial agonist P4S were determined. When the a1 Q241L mutation is made in
both a1 subunits the EC50 for activation by GABA is shifted to higher concen-
tration and the ability of neurosteroids to potentiate responses to a low concen-
tration of GABA is lost. Conversely, when the a1 Q241W mutation is made in
both subunits the EC50 for GABA is shifted to lower concentration, the relative
ability of P4S to activate the receptor is increased and potentiation by neuroste-
roids is lost. For both, mutation of only one a1 subunit did not produce the full
effect of mutating both sites. Hence, the presence of a single wild-type site is
sufficient to mediate all effects seen in macroscopic responses. Overall, muta-
tion of the a1 subunit between the g and b subunits had a larger effect, which
might reflect a subtle difference between sites or a consequence of subunit po-
sition. The data demonstrate that at a macroscopic level the presence of a single
wild-type steroid-binding site is sufficient to mediate the responses to steroid.
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The general anesthetic etomidate exerts its major clinical actions through po-
tentiation of GABAA receptor activation. GABAA receptors are pentameric,
